| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872028 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 10 Pages |
Abstract
Conclusion: In Indian women, LVI was the strongest independent prognostic factor for OS, DFS, and local recurrence, irrespective of nodal status and systemic adjuvant treatment. Although LVI may not be a contraindication for BCT, as has been proposed by certain groups, it is necessary to define its role in prospective studies in determining local and systemic treatment.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ketayun A. (F.R.C.R. (Lond.)), Ashwini N. M.D., D.N.B., Roshan F. M.D., Rajiv (F.R.C.R.), Rajendra M.S., Rohini B.Sc., D.C.M., Shyam Kishore M.D., D.N.B.,